ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Survival"

  • 2017 American Transplant Congress

    The Impact of Scleroderma Diagnosis on Lung Transplant Outcomes: A Single Center's Experience.

    H. Memon, A. Frost, E. Graviss, D. Nguyen, A. Goodarzi, N. Sinha.

    Medicine, Weill Cornell Medical College, Houston Methodist Hospital, Houston, TX

    Patients with scleroderma (SSC) associated restrictive lung disease (RD) and pulmonary hypertension (PH) are often turned down for lung transplant due to associated co-morbidities, particularly…
  • 2017 American Transplant Congress

    Influence of Tacrolimus Metabolism Rate on Patients' Survival After Renal Transplantation.

    G. Thölking, J. Steinke, K. Schuette-Nuetgen, H. Pavenstädt, B. Suwelack, S. Reuter.

    Department of Medicine D, Division of General Internal Medicine, Nephrology and Rheumatology, University Hospital of Münster, Münster, Germany

    Introduction: Tacrolimus (Tac) is an integral part of the immunosuppressive regimen after renal transplantation (RTx). A fast Tac metabolism rate defined as the Tac blood…
  • 2017 American Transplant Congress

    Multicenter Validation of a Clinicopathologic Risk Score to Predict Hepatocellular Carcinoma Recurrence Following Liver Transplantation: Analysis of 4984 Patients from the US Multicenter HCC Transplant Consortium.

    V. Agopian, On Behalf of the US Multicenter HCC Transplant Consortium.

    UCLA, LA

    Objective: Recurrence of hepatocellular carcinoma (HCC) following liver transplantation (LT) negatively impacts survival. Existing risk prediction models either lack external validation or limit their scope…
  • 2017 American Transplant Congress

    VO2peak: A Significant Marker of All-Cause Mortality Among Patients with End-Stage Renal Disease Being Evaluated for Kidney Transplant.

    H. Chakkera,1 M. Temkit,1 B. Kaplan,1 G. Gaesser,2 R. Heilman,1 H. Khamash,1 K. Reddy,1 E. Steidley,1 A. Mathur,1 S. Nair,1 G. Mour,1 J. Huskey,1 A. Moss,1 A. Singer,1 W. Hewitt,1 I. Qaqish,1 S. Behmen,1 S. Angadi.2

    1Mayo Clinic AZ, Phoenix; 2ASU, Tempe

    Background: Peak oxygen uptake (VO2peak), obtained from cardiopulmonary exercise testing is a marker of functional capacity and a modifiable risk factor. VO2peak is a strong…
  • 2017 American Transplant Congress

    Liver Regeneration in Porcine Hepatectomy Model.

    H. Chen, D. Joo, M. Shaheen, J. Yang, S. Nyberg.

    Department of Transplantation Surgery, Mayo Clinic, Rochester, MN

    Background: Acute Liver Failure (ALF) is a serious condition. A substantial number of donor livers (10%) are used to save ALF patients. Supportive therapies such…
  • 2017 American Transplant Congress

    A Nationwide Global Strategy for Kidney Transplantation with Controlled Cardiac Death Donor (cDCD) Has Improved Global Results. Spanish Multicentre SENTRA-GEODAS Group.

    J. Portoles,1,2 M. Perez-Saez,2,3 D. Janeiro,1,2 E. Melilli,2 N. Maruri Kareaga,2 E. de Souza,2 F. Llamas,2 J. Espi,2 P. Martin Moreno,2 D. Navarro,2 A. Sancho-Calabuig,2 M. Rodriguez-Ferrero,2 D. Hernandez,2 J. Pascual.2,3

    1Nephrology, Hospital Puerta de Hierro, Majadahonda, Spain; 2GEODAS-SENTRA Public Health Research Net RedinRen16/009/009 RETYC ISCIII, Madrid, Spain; 3Nephrology, Hospital del Mar, Barcelona, Spain

    Background: Controlled donation after cardiac death (cDCD) programs are running in US for years and some European countries has recently started on it. National transplant…
  • 2017 American Transplant Congress

    Cardiovascular Disease in Japanese Kidney Transplant Recipients.

    M. Okumi, K. Unagami, D. Fujimori, K. Hata, T. Hirai, H. Ishida, K. Tanabe, Japan Academic Consortium of Kidney Transplantation (JACK).

    Urology, Tokyo Women's Medical University, Tokyo, Japan

    BackgroundGlobally, among kidney transplant recipients (KTRs), cardiovascular diseases (CVDs) have been the most frequent cause of death with a preserved transplant kidney function, referred to…
  • 2017 American Transplant Congress

    Hispanic Paradox in Patients with Liver Cirrhosis.

    K. Atiemo, J. Caicedo, D. Ganger, E. Gordon, L. Zhao, S. Montag, H. Maddur, L. VanWagner, L. Kulik, S. Flamm, S. Goel, A. Kho, R. Kang, M. Abecassis, D. Ladner.

    Northwestern University Transplant Research Collaborative, Chicago

    IntroductionA paradoxical survival advantage for Hispanics compared to non-Hispanic whites (NHW) has been well described for many clinical conditions e.g diabetes however, with respect to…
  • 2017 American Transplant Congress

    A Dedicated Young Adult Service with a Youth Worker Increases Engagement of Teenagers and Young Adults with Kidney Transplantation and Impacts Favourably on Clinical Outcomes.

    D. Cross, P. Harden.

    Oxford Transplant Centre, Oxford University Hospital NHS Foundation Trust, Oxford, United Kingdom

    Transition from pediatric to adult care is associated with a high risk of transplant loss, increased morbidity and mortality. Frequently there is poor engagement by…
  • 2017 American Transplant Congress

    Results of Stem Cell and Renal Transplantation in Patients with End Stage Renal Disease After Plasma Cell Dyscrasias.

    C. Moliz,1 B. Redondo,1 M. Molina,1 E. Morales,1 E. Gonzalez,1 J. Cabrera,2 A. Andres.1

    1Nephrology Department, Hospital Universitario 12 de Octubre, Madrid, Spain; 2Nephrology Department, Hospital Evangelico y Hospital Militar, Montevideo, Uruguay

    Introduction: Plasma cell dyscrasias (PCD) are a cause of end stage renal disease (ESRD). Traditionally, renal transplantation (RT) has been avoided in these patients due…
  • « Previous Page
  • 1
  • …
  • 46
  • 47
  • 48
  • 49
  • 50
  • …
  • 66
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences